TP53 mutation in leukemia can occur in the context of somatic and germline mutations, the latter of which is associated with Li-Fraumeni syndrome leads to the development of specific solid tumors and is less likely to arise in diverse tissues [41]. Here, TP53 is linked to leukemia.